Users Online: 140
Home Print this page Email this page
Home About us Editorial board Search Browse articles Submit article Ahead of Print Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 9  |  Issue : 1  |  Page : 14

Impact of admission calcium-phosphate product on 1-year mortality among hospitalized patients


1 Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi; Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
2 Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
3 Department of Internal Medicine, University of Pittsburgh Medical Center Pinnacle, Harrisburg, PA, USA
4 Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi, USA
5 Department of Internal Medicine, University of Arizona, Tucson, Arizona, USA
6 Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL, USA

Correspondence Address:
Dr. Wisit Cheungpasitporn
Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, 2500 N State Street, Jackson 39216, Mississippi
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/abr.abr_249_19

Rights and Permissions

Background: Calcium-phosphate product is associated with mortality among patients with end-stage kidney disease on dialysis. However, clinical evidence among hospitalized patients is limited. The objective of this study was to investigate the relationship between admission calcium-phosphate product and 1-year mortality in hospitalized patients. Materials and Methods: All adult patients admitted to a tertiary referral hospital in 2009–2013 were studied. Patients who had both available serum calcium and phosphate measurement within 24 h of hospital admission were included. Admission calcium-phosphate product (calcium × phosphate) was stratified based on its distribution into six groups: <21, 21–<27, 27–<33, 33–<39, 39–<45, and ≥45 mg2/dL2. Multivariate cox proportional hazard analysis was performed to evaluate the association between admission calcium-phosphate product and 1-year mortality, using the calcium-phosphate product of 33–<39 mg2/dL2 as the reference group. Results: A total of 14,772 patients were included in this study. The mean admission calcium-phosphate product was 34.4 ± 11.3 mg2/dL2. Of these patients, 3194 (22%) died within 1 year of hospital admission. In adjusted analysis, admission calcium-phosphate product of ≥45 mg2/dL2 was significantly associated with increased 1-year mortality with hazard ratio of 1.41 (95% 95% confidence interval 1.25–1.67), whereas lower admission calcium-phosphate product was not significantly associated with 1-year mortality. Conclusion: Elevated calcium-phosphate product was significantly associated with increased 1-year mortality in hospitalized patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed226    
    Printed21    
    Emailed0    
    PDF Downloaded36    
    Comments [Add]    
    Cited by others 1    

Recommend this journal